首页> 外国专利> Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (miR145) and micro-RNA 212 (miR212)

Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (miR145) and micro-RNA 212 (miR212)

机译:微小RNA 132(miR132),微小RNA 145(miR145)和微小RNA 212(miR212)对人巨细胞病毒复制的调节

摘要

The present invention related to miR145, miR132, miR212, and the genes or gene products regulated by these miRNAs. miR145 is downregulated in cells infected with HCMV. This downregulation modulates expression of miR145 target genes, including IRS-1. Transfection of cells with a miR145 agent, such as a miR145 mimetic, reduces HCMV replication and protein expression. miR132 and miR212 are upregulated in cells infected with HCMV. This upregulation modulates expression of miR132 and miR212 target genes, including MeCP2 and RICS. Transfection of cells with a miR132 and/or a miR212 antagonist reduces HCMV replication and protein expression. Accordingly, the invention provides methods of attenuating HCMV replication by modulating, for example, miR145, miR132, and/or miR212, and targets thereof. Also provided are methods of detecting an HCMV infection, and compositions and kits useful for attenuating HCMV replication.
机译:本发明涉及miR145,miR132,miR212以及由这些miRNA调节的基因或基因产物。 miR145在感染HCMV的细胞中下调。这种下调调节包括IRS-1在内的miR145靶基因的表达。用miR145试剂(例如miR145模拟物)转染细胞会降低HCMV复制和蛋白质表达。在感染了HCMV的细胞中,miR132和miR212被上调。这种上调调节了miR132和miR212靶基因(包括MeCP2和RICS)的表达。用miR132和/或miR212拮抗剂转染细胞会降低HCMV复制和蛋白质表达。因此,本发明提供了通过调节例如miR145,miR132和/或miR212及其靶来减弱HCMV复制的方法。还提供了检测HCMV感染的方法,以及用于减弱HCMV复制的组合物和试剂盒。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号